dextroamphetamine has been researched along with glycine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Blanc, G; Darracq, L; Drouin, C; Glowinski, J; Tassin, JP | 1 |
Hanstock, CC; Nakashima, TT; O'Donnell, T; Rotzinger, S; Silverstone, PH; Ulrich, M | 1 |
Arnold, LE; Calarge, C; DiSilvestro, R; Farmer, C | 1 |
Abdel-Rasoul, M; Arnold, LE; Bozzolo, D; Bozzolo, H; Crowl, L; Disilvestro, RA; Fernandez, S; Joseph, E; Mo, X; Ramadan, Y; Thompson, S | 1 |
2 trial(s) available for dextroamphetamine and glycine
Article | Year |
---|---|
Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Ferritins; Glycine; Humans; Iron Deficiencies; Male; Pilot Projects; Severity of Illness Index; Treatment Outcome | 2010 |
Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Copper; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycine; Humans; Iron; Male; Neuropsychological Tests; Pilot Projects | 2011 |
5 other study(ies) available for dextroamphetamine and glycine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Stimulation of metabotropic but not ionotropic glutamatergic receptors in the nucleus accumbens is required for the D-amphetamine-induced release of functional dopamine.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics, Opioid; Animals; Benzoates; Brain Chemistry; Central Nervous System Stimulants; Dextroamphetamine; Dopamine; Excitatory Amino Acid Antagonists; Glycine; Hyperkinesis; Male; Morphine; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Ventral Tegmental Area | 2001 |
Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain.
Topics: Animals; Anticonvulsants; Brain Chemistry; Central Nervous System Stimulants; Creatine; Dextroamphetamine; Glucose-6-Phosphate; Glycine; Inositol; Inositol Phosphates; Lithium; Magnetic Resonance Spectroscopy; Male; Phosphocreatine; Phosphorylcholine; Rats; Rats, Sprague-Dawley; Valproic Acid | 2003 |